postECTRIMS

@POSTECTRIMS

Follow us for updates. Canal dirigido a HCP, organizaciones e instituciones interesados en la .

Madrid
Vrijeme pridruživanja: rujan 2011.

Tweetovi

Blokirali ste korisnika/cu @POSTECTRIMS

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @POSTECTRIMS

  1. prije 1 sat

    Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis.

    Poništi
  2. 4. velj

    Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.

    Poništi
  3. 4. velj

    Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls.

    Poništi
  4. 4. velj

    Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis.

    Poništi
  5. 4. velj

    Neurodegeneration in multiple sclerosis and neuromyelitis optica.

    Poništi
  6. 3. velj
    Poništi
  7. 3. velj

    Evaluation of The Expression Levels of Three Long Non-Coding RNAs in Multiple Sclerosis.

    Poništi
  8. 3. velj

    Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression.

    Poništi
  9. 2. velj

    A Potential Life-Threatening Reaction to Glatiramer Acetate in Rett Syndrome.

    Poništi
  10. 2. velj

    Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations.

    Poništi
  11. 2. velj
    Poništi
  12. 1. velj

    Intrathecal Injection of Peripherally Mobilized Blood Stem Cells to Treat Multiple Sclerosis.

    Poništi
  13. 1. velj

    Functional and structural changes in the visual pathway in multiple sclerosis.

    Poništi
  14. 31. sij

    Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.

    Poništi
  15. 31. sij

    Functional and structural changes in the visual pathway in multiple sclerosis.

    Poništi
  16. 31. sij

    Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

    Poništi
  17. 31. sij

    Os recordamos que la XIII edición de se celebrará los días 2 y 3 de Octubre en Madrid.

    Poništi
  18. 31. sij

    Serum and saliva total tau protein as a marker for relapsing-remitting multiple sclerosis.

    Poništi
  19. 31. sij

    Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.

    Poništi
  20. 30. sij

    SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·